GEPIA3: Enhanced drug sensitivity and interaction network analysis for cancer research
A pan-cancer platform for gene-expression, drug-sensitivity, interaction-network, regulatory-network, and RNA-alteration analyses.
Publications
Five representative publications spanning bioinformatics resources, cancer genomics, and single-cell analysis.
A pan-cancer platform for gene-expression, drug-sensitivity, interaction-network, regulatory-network, and RNA-alteration analyses.
A standalone GEPIA extension for deconvolution-based cell-type proportion, correlation, differential-expression, and survival analyses of TCGA and GTEx data.
The GEPIA2021 server has shown intermittent availability; the publication links remain accessible.
A PCAWG study connecting recurrent RNA alterations—including expression, splicing, promoter use, and gene fusions—to genomic changes across cancer types.
The author list shown here is abbreviated; use the official record for the complete consortium author list.
A systematic benchmark of SNV detection from single-cell RNA sequencing, evaluating performance across sequencing depth, gene expression, allele frequency, and genomic context.
The original AnnoLnc web server integrated multidimensional annotations for novel human lncRNAs; its current successor resource is AnnoLnc2.
Fenglin Liu contributed to the original AnnoLnc pilot build and is listed in the previous AnnoLnc development team, not the AnnoLnc2 development team.